Scotia Capital Inc. increased its holdings in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 4.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 219,199 shares of the pharmacy operator’s stock after buying an additional 10,175 shares during the period. Scotia Capital Inc.’s holdings in Walgreens Boots Alliance were worth $11,986,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in WBA. Nelson Roberts Investment Advisors LLC acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $25,000. Meridian Wealth Management LLC acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $25,000. Weaver Consulting Group acquired a new position in Walgreens Boots Alliance during the first quarter valued at approximately $27,000. Sageworth Trust Co bought a new stake in shares of Walgreens Boots Alliance during the second quarter worth $27,000. Finally, Trustcore Financial Services LLC bought a new stake in shares of Walgreens Boots Alliance during the first quarter worth $31,000. Institutional investors own 59.80% of the company’s stock.

Shares of Walgreens Boots Alliance stock traded down $2.50 during trading on Thursday, hitting $55.56. The company’s stock had a trading volume of 6,713,022 shares, compared to its average volume of 5,871,166. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. Walgreens Boots Alliance Inc has a 52 week low of $49.03 and a 52 week high of $86.31. The stock has a market cap of $50.21 billion, a price-to-earnings ratio of 9.23, a price-to-earnings-growth ratio of 1.39 and a beta of 0.88. The stock has a 50-day moving average price of $52.32 and a two-hundred day moving average price of $55.15.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.05. Walgreens Boots Alliance had a net margin of 3.53% and a return on equity of 22.08%. The company had revenue of $34.59 billion for the quarter, compared to analysts’ expectations of $34.52 billion. During the same quarter in the previous year, the firm posted $1.53 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up .7% on a year-over-year basis. On average, equities analysts predict that Walgreens Boots Alliance Inc will post 5.98 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 12th. Investors of record on Tuesday, August 20th will be paid a $0.458 dividend. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. The ex-dividend date of this dividend is Monday, August 19th. This represents a $1.83 annualized dividend and a dividend yield of 3.30%. Walgreens Boots Alliance’s payout ratio is currently 30.40%.

WBA has been the topic of a number of research reports. Morgan Stanley decreased their target price on shares of Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. ValuEngine raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, June 28th. Bank of America decreased their target price on shares of Walgreens Boots Alliance from $53.00 to $51.00 and set an “underperform” rating on the stock in a research note on Monday, June 3rd. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Wednesday. Finally, Deutsche Bank initiated coverage on shares of Walgreens Boots Alliance in a research note on Thursday. They set a “sell” rating on the stock. Seven equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and four have given a buy rating to the stock. Walgreens Boots Alliance has an average rating of “Hold” and an average price target of $63.65.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the company’s stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the sale, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 15.73% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: Oversold

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.